5Allen ML,Deslaurier M,Andrews CW,et al. Identificatoin and characterization of mutations in hepatitis B virus reisistant to lamivudine [J]. Hepatology,1998;16:70-7.
5Lai CL,Chien RN,Leung NWY，et al.A one -year trial of lamivudine for chronic hepatitis B[J]．N Engl J Med，1998，339：61.
6Sokal E，Roberta EA，Mieli-Vergani G,et al.Dose—finding and safety of Iamivudine in children and adolescents with ehronie hepatitis B(abstract)[J].Hepatology,1998,28(4pt2)489A.
7Lai CI,Ching CK,Tung AKM，et a1．Lamivudine is effective in suppreasing bepatitis B virus DNA in chinese hepatitis B surface antigen carriers:a placebo-controlled trial[J]．Hepatology，1997，25：241.
8Allen MI，Dealauriers M，Andrews W，et a1．Identification and characterization of mutations in hepatitis B virus resistant to almivudine[J].Hepatology ,1998，27：1670．
9Chayama K，Yoshiyuki S，Kobayashi M，et al,Emergence and takeover of YMDD matif matant hepatitis B virus duing long-term lamivudine therapy and re-takeover by wild type after cessation of therapy[J].Hepatology,1998.27：1711.
10Niesters HGM,Honkoop P，Haagama EB，et a1．Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment [J]．J Infect Dis，1998，177：1382．
